Jan Vydra, MD, PhD
Institute of Hematology and Blood Transfusion, Prague, Czech Republic
1
1
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Petr Lesný, MD, PhD
Institute of Hematology and Blood Transfusion, Prague, Czech Republic
Shared therapeutic areas:
Worked with same sponsors:
Beata Holkova, MD
Massey Cancer Center
Shared therapeutic areas:
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Jae Park, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Partow Kebriaei, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Ryotaro Nakamura
City of Hope Medical Center
Shared therapeutic areas:
Jorge Cortes, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Qifa Liu
Nanfang Hospital, Southern Medical University
Shared therapeutic areas:
Mitchell S Cairo, MD
New York Medical College
Shared therapeutic areas:
Farhad Ravandi-Kashani, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial
All 1 trials loaded